« Back to Record
Citation APA

Marangoni, E., Laurent, C., Coussy, F., El-Botty, R., Château-Joubert, S., Servely, J., De Plater, L., Assayag, F., Dahmani, A., Montaudon, E., Nemati, F., Fleury, J., Vacher, S., Gentien, D., Rapinat, A., Foidart, P., Sounni, N., Noël, A., Vincent-Salomon, A., Lae, M., Decaudin, D., Roman-Roman, S., Bieche, I., Piccart-Gebhart, M., & Reyal, F. (2018). Capecitabine efficacy is correlated with tymp and rb1 expression in pdx established from triple-negative breast cancers. Clinical cancer research, 24(11), 2605-2615. doi:10.1158/1078-0432.CCR-17-3490


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/273231

Marangoni, E., Laurent, C., Coussy, F., El-Botty, R., Château-Joubert, S., Servely, J., De Plater, L., Assayag, F., Dahmani, A., Montaudon, E., Nemati, F., Fleury, J., Vacher, S., Gentien, D., Rapinat, A., Foidart, P., Sounni, N., Noël, A., Vincent-Salomon, A., Lae, M., Decaudin, D., Roman-Roman, S., Bieche, I., Piccart-Gebhart, M., & Reyal, F. (2018). Capecitabine efficacy is correlated with tymp and rb1 expression in pdx established from triple-negative breast cancers. Clinical cancer research, 24(11), 2605-2615. doi:10.1158/1078-0432.CCR-17-3490